Biogen BIIB
NASDAQ BIIB
$253.40 +2.92 (+1.17%)
At close: Nov 13, 2026 · 4:00 PM EST

Biogen (BIIB) Payout Ratio (2017 - 2018)

Updated

Biogen's (BIIB) Payout Ratio was 0.02 for FY2020.

Analysis

Biogen (BIIB) Payout Ratio (2017 - 2018) Analysis & Trends

  • The FY2020 figure ranks as the highest annual Payout Ratio since FY2017.
  • According to Business Quant data, Payout Ratio came in at 0.01 in FY2018 (-93.1%) and 0.12 in FY2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn
5 Novartis Ag 306.35 Bn 279.93 Bn -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn
10 Biogen 37.46 Bn 26.77 Bn 2.06 Bn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 0.01
Dec 31, 2017 0.12
Sep 30, 2017 0.09
Jun 30, 2017 0.09
Mar 31, 2017 0.09
API Access

Biogen Payout Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=payout-ratio&ticker=BIIB&period=max&api_key=YOUR_API_KEY